Combination therapy improves outcomes for advanced triple-negative breast cancer

Published Date: 22 Aug 2025

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In leukemia, allogeneic HCT is beneficial following primary induction failure.

2.

FDA Approves Sickle Cell Gene Therapy for Young Kids

3.

According to a study, male testicular cancer risk is linked to neurodevelopmental disorders.

4.

Research exposes far-reaching toll of financial hardship on patients with cancer

5.

Combination Treatment May Improve Multiple Myeloma Outcomes


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot